Structural evaluation of an alternative Protein A biomimetic ligand for antibody purification

被引:0
作者
Telma Barroso
Ricardo J. F. Branco
Ana Aguiar-Ricardo
Ana C. A. Roque
机构
[1] Universidade Nova de Lisboa,REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia
来源
Journal of Computer-Aided Molecular Design | 2014年 / 28卷
关键词
Antibody; Biomimetic ligand; Affinity chromatography; Molecular recognition and binding; Molecular dynamics simulations;
D O I
暂无
中图分类号
学科分类号
摘要
Affinity chromatography is one of the most common techniques employed at the industrial-scale for antibody purification. In particular, the purification of human immunoglobulin G (hIgG) has gained relevance with the immobilization of its natural binding counterpart—Staphylococcus aureus Protein A (SpA) or with the recent development of biomimetic affinity ligands, namely triazine-based ligands. These ligands have been developed in order to overcome economic and leaching issues associated to SpA. The most recent triazine-based ligand—TPN-BM, came up as an analogue of 2-(3-amino-phenol)-6-(4-amino-1-naphthol)-4-chloro-sym-triazine ligand also known as ligand 22/8 with improved physico-chemical properties and a greener synthetic route. This work intends to evaluate the potential of TPN-BM as an alternative affinity ligand towards antibody recognition and binding, namely IgG, at an atomic level, since it has already been tested, after immobilization onto chitosan-based monoliths and demonstrated interesting affinity behaviour for this purpose. Herein, combining automated molecular docking and molecular dynamics simulations it was predicted that TPN-BM has high propensity to bind IgG through the same binding site found in the crystallographic structure of SpA_IgG complex, as well as theoretically predicted for ligand 22/8_IgG complex. Furthermore, it was found that TPN-BM established preferential interactions with aromatic residues at the Fab domain (Trp 50, Tyr 53, Tyr 98 and Trp 100), while in the Fc domain the main interactions are based on hydrogen bonds with pH sensitive residues at operational regime for binding and elution like histidines (His 460, His 464, His 466). Moreover, the pH dependence of TPN-BM_IgG complex formation was more evident for the Fc domain, where at pH 3 the protonation state and consequently the charge alteration of histidine residues located at the IgG binding site induced ligand detachment which explains the optimal elution condition at this pH observed experimentally.
引用
收藏
页码:25 / 34
页数:9
相关论文
共 50 条
[21]   Highly efficient antibody purification with controlled orientation of protein A on magnetic nanoparticles [J].
Kim, Sunghyun ;
Sung, Daekyung ;
Chang, Jeong Ho .
MEDCHEMCOMM, 2018, 9 (01) :108-112
[22]   Antibody purification with protein A attached supermacroporous poly(hydroxyethyl methacrylate) cryogel [J].
Alkan, Hueseyin ;
Bereli, Nilay ;
Baysal, Zuebeyde ;
Denizli, Adil .
BIOCHEMICAL ENGINEERING JOURNAL, 2009, 45 (03) :201-208
[23]   Development of an automated mid-scale parallel protein purification system for antibody purification and affinity chromatography [J].
Zhang, Chi ;
Long, Alexander M. ;
Swalm, Brooke ;
Charest, Ken ;
Wang, Yan ;
Hu, Jiali ;
Schulz, Craig ;
Goetzinger, Wolfgang ;
Hall, Brian E. .
PROTEIN EXPRESSION AND PURIFICATION, 2016, 128 :29-35
[24]   N- Heterocyclic- based adsorbents for antibody purification- effect of ligand structure [J].
Mountford, Simon J. ;
Daly, Rachel ;
Campi, Eva M. ;
Bhagwat, Anjali ;
Robinson, Andrea J. ;
Hearn, Milton T. W. .
JOURNAL OF MOLECULAR RECOGNITION, 2014, 27 (05) :285-295
[25]   Phage display combinatorial libraries of short peptides: ligand selection for protein purification [J].
Gaskin, DJH ;
Starck, K ;
Turner, NA ;
Vulfson, EN .
ENZYME AND MICROBIAL TECHNOLOGY, 2001, 28 (9-10) :766-772
[26]   Molecular modeling for the design of a biomimetic chimeric ligand. Application to the purification of bovine heart L-lactate dehydrogenase [J].
Labrou, NE ;
Eliopoulos, E ;
Clonis, YD .
BIOTECHNOLOGY AND BIOENGINEERING, 1999, 63 (03) :322-332
[27]   Combinatorial de novo design and application of a biomimetic affinity ligand for the purification of human anti-HIV mAb 4E10 from transgenic tobacco [J].
Platis, Dimitris ;
Maltezos, Anastasios ;
Ma, Julian K-C. ;
Labrou, Nikolaos E. .
JOURNAL OF MOLECULAR RECOGNITION, 2009, 22 (06) :415-424
[28]   Application of the Protein Maker as a platform purification system for therapeutic antibody research and development [J].
Helie, Genevieve ;
Parat, Marie ;
Masse, Frederic ;
Gerdts, Cory J. ;
Loisel, Thomas P. ;
Matte, Allan .
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2016, 14 :238-244
[29]   Design, synthesis and application of benzyl-sulfonate biomimetic affinity adsorbents for monoclonal antibody purification from transgenic corn [J].
Maltezos, Anastasios ;
Platis, Dimitris ;
Vlachakis, Dimitrios ;
Kossida, Sophia ;
Marinou, Marigianna ;
Labrou, Nikolaos E. .
JOURNAL OF MOLECULAR RECOGNITION, 2014, 27 (01) :19-31
[30]   A comparison of Protein A chromatographic stationary phases: Performance characteristics for monoclonal antibody purification [J].
Liu, Zhuo ;
Mostafa, Sigma S. ;
Shukla, Abhinav A. .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2015, 62 (01) :37-47